Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. (Q46814329)

25 December 2017

title

Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. (English)

1 reference

25 December 2017

0 references

Chris P Stephenson

1

1 reference

25 December 2017

Emily Karanges

series ordinal

2

1 reference

25 December 2017

Iain S McGregor

series ordinal

3

1 reference

25 December 2017

publication date

9 November 2012

1 reference

25 December 2017

Australian and New Zealand Journal of Psychiatry

published in

1 reference

25 December 2017

volume

47

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

74-87

1 reference

25 December 2017

Increasing off-label use of antipsychotic medications in the United States, 1995-2008

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Supping with the devil? The dangers of liaisons between pharma and our profession.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Atypical antipsychotics in the elderly: a review of therapeutic trends and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Trends in medication treatment for ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Antidepressant drug effects and depression severity: a patient-level meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Pharmacotherapeutic trends in 2231 psychiatric inpatients with bipolar depression from the International AMSP Project between 1994 and 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Novel melatonin-based therapies: potential advances in the treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Antiepileptic drugs in Australia: 2002-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Anxiolytic, hypnotic and sedative medication use in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Patterns of antipsychotic medication use in Australia 2002-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Australian national trends in stimulant dispensing: 2002-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Changes in psychological distress in Australian adults between 1995 and 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Withdrawing Benzodiazepines in Primary Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Antiepileptic drugs in epilepsy and other disorders--a population-based study of prescriptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

National trends in psychotropic medication polypharmacy in office-based psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

National trends in the outpatient diagnosis and treatment of bipolar disorder in youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

The role of alprazolam for the treatment of panic disorder in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

National patterns in antidepressant medication treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Is depression overdiagnosed? Yes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Public attitudes towards the acceptability of using drugs to treat depression and ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

The global market for ADHD medications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Adolescent prescription ADHD medication abuse is rising along with prescriptions for these medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

For richer, for poorer, in sickness and in health: the entanglement of science and marketing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Sifting the evidence-what's wrong with significance tests?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Trends in utilization of antiepileptic drugs in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Tolerability and safety of fluvoxamine and other antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Stimulant medication use in children: a 12-year perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

21 January 2018

Identifiers

DOI

10.1177/0004867412466595

1 reference

25 December 2017

PubMed ID

23144164

1 reference

25 December 2017